No Data
US Stock MarketDetailed Quotes
USAS Americas Gold And Silver
Watchlist
0.3420
-0.0090-2.56% Close 09/27 16:00 ET
0.3650+0.0230+6.73%
Post 19:54 ET
0.3685High0.3420Low209.52KVolume
0.3568Open0.3510Pre Close72.93KTurnover0.10%Turnover RatioLossP/E (TTM)74.04MMarket Cap0.759952wk HighLossP/E (Static)216.48MShares0.340052wk Low1.06P/B73.34MFloat Cap21.8160Historical High--Dividend TTM214.43MShs Float0.3400Historical Low--Div YieldTTM7.55%Amplitude0.3480Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Americas Gold And Silver Company
Americas Gold & Silver Corp. engages in the acquisition, exploration, development, and exploration of mineral resource properties. It operates through the following segments: Cosalá Operations, Galena Complex, Relief Canyon, and Corporate and Other. The Cosalá Operations segment operates in Mexico. The Galena Complex and Relief Canyon segments focuses on the United States. The company was founded by Peter Jude Hawley on May 12, 1998 and is headquartered in Toronto, Canada.
Revenue Breakdown
Business
Unit:USD
12/31/2022
Stock NameRevenueRatio
Cosalá Operations53.42M62.83%
Galena Complex31.41M36.94%
Relief Canyon193K0.23%
News
4 Analysts Have This to Say About Americas Gold And Silver
Within the last quarter, Americas Gold And Silver (AMEX:USAS) has observed the following analyst ratings: BullishSomewhat BullishIndifferentSomewhat BearishBearishTotal Ratings30100Last 30D100001M Ago
Roth MKM Reiterates Buy on Americas Gold And Silver, Maintains $0.9 Price Target
Roth MKM analyst Joe Reagor reiterates Americas Gold And Silver (AMEX:USAS) with a Buy and maintains $0.9 price target.
Americas Gold and Silver GAAP EPS of -$0.03 Misses by $0.02, Revenue of $24.2M Misses by $2.79M
Comments
$Americas Gold And Silver(USAS.US$ Looking like the Titanic
ColumnsToday's pre-market stock movers: PLUG, CMPI, JNJ, LMT and more
Gainers:
• $Checkmate Pharmaceuticals(CMPI.US$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics(AXSM.US$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $Super Micro Computer(SMCI.US$ +14.3% (earnings report)
• $Plug Power(PLUG.US$ +9.24% (t...
• $Checkmate Pharmaceuticals(CMPI.US$ +331.5% (Regeneron Pharma (REGN) to acquire CMPI for $10.50/share in cash)
• $Axsome Therapeutics(AXSM.US$ +27.9% (received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the New Drug Application for its AXS-05 product candidate for the treatment of major depressive disorder)
• $Super Micro Computer(SMCI.US$ +14.3% (earnings report)
• $Plug Power(PLUG.US$ +9.24% (t...
16
1
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--